Andrea Mccart
Toronto, ON, Canada
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
ASO Visual Abstract: Decision-Making and Decision-Satisfaction Following Cytoreductive Surgery and HIPEC for GI Malignancies: A Qualitative Study.
Journal: Annals of surgical oncology
Published: April 10, 2026
Patients' Lived Experiences After Cytoreductive Surgery and HIPEC for Peritoneal Carcinomatosis from GI Malignancies: A Qualitative Study.
Journal: Annals of surgical oncology
Published: November 13, 2025
Decision-Making and Decision Satisfaction Following Cytoreductive Surgery and HIPEC for GI Malignancies: A Qualitative Study.
Journal: Annals of surgical oncology
Published: November 13, 2025
Evidence-Based Strategies for the Treatment of Peritoneal Malignancies during Health Care Resource Restriction: The COVID-19 Pandemic.
Journal: Current oncology (Toronto, Ont.)
Published: July 08, 2020
BAP1 haploinsufficiency predicts a distinct immunogenic class of malignant peritoneal mesothelioma.
Journal: Genome medicine
Published: August 20, 2018
Canadian Surgery Forum 2018: St. John's, NL Sept. 13-15, 2018.
Journal: Canadian journal of surgery. Journal canadien de chirurgie
Published: August 01, 2018
In Situ Vaccination after Accelerated Hypofractionated Radiation and Surgery in a Mesothelioma Mouse Model.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: February 14, 2017
Lister strain vaccinia virus with thymidine kinase gene deletion is a tractable platform for development of a new generation of oncolytic virus.
Journal: Gene therapy
Published: August 26, 2014
Showing 1-8 of 8
Last Updated: 09/26/2026